Physician profile
Khalid Khan
NPI 1558388199
$1,609.66
in general payments reported to CMS, 2019-2025
13 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $298 · 2021: $455 · 2022: $272 · 2023: $151 · 2024: $81.89 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $429.03 | 2019-2022 | |
| Medtronic, INC. | $223.11 | 2022-2023 | Closurefast |
| Novo Nordisk INC | $195.11 | 2019-2022 | |
| Seagen INC. | $125.00 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $123.50 | 2025 | Fasenra |
| Novartis Pharmaceuticals Corporation | $101.94 | 2020 | |
| Abbott Laboratories | $100.18 | 2021 | |
| Allergan, INC. | $90.35 | 2019 | |
| Lilly USA, LLC | $84.80 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.89 | 2024 | Jardiance |
| Pfizer INC. | $18.86 | 2025 | |
| Ethicon INC. | $17.98 | 2025 | Monarch Platform |
| Glaxosmithkline, LLC. | $17.91 | 2023 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.